{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Proto Labs, Inc.
Proto Labs, Inc. Hits New 52-Week High of $80.52, Up 146.41%
Proto Labs, Inc. has achieved a new 52-week high, reflecting a strong performance with a significant return over the past year. The company maintains a market capitalization of USD 1,332 million and demonstrates efficient inventory management. Despite challenges in long-term growth, it shows financial stability and resilience in the specialty chemicals industry.
Proto Labs, Inc. Hits New 52-Week High of $78.41, Up 145.53%
Proto Labs, Inc. has achieved a new 52-week high, reflecting a strong one-year return that significantly exceeds the S&P 500. With a market capitalization of USD 1,313 million, the company showcases efficient inventory management and positive revenue trends, despite facing long-term growth challenges and maintaining a low debt-to-equity ratio.
Proto Labs, Inc. Hits New 52-Week High of $76.17
Proto Labs, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year. The company boasts a market capitalization of USD 1,313 million and an efficient inventory turnover ratio. Despite challenges in long-term growth, it maintains a positive return on equity and has reduced raw material costs.
Proto Labs, Inc. Hits New 52-Week High of $75.48, Up 134.48%
Proto Labs, Inc. has achieved a new 52-week high, reflecting a strong performance with a significant increase over the past year. The company, with a market cap of USD 1,313 million, demonstrates resilience despite long-term growth challenges, showcasing impressive financial metrics and a competitive position in the specialty chemicals industry.
Proto Labs, Inc. Hits New 52-Week High of $74.89, Up 132%
Proto Labs, Inc. has achieved a new 52-week high, reflecting a significant increase in its stock price over the past year. The company, with a market capitalization of USD 1,313 million, demonstrates strong operational metrics and efficient inventory management, despite facing challenges in long-term growth.
Proto Labs, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Market Performance
Proto Labs, Inc. has recently adjusted its valuation, with its current price at $63.68. Over the past year, the company has achieved a return of 79.94%, outperforming the S&P 500. Key financial metrics include a P/E ratio of 60 and a return on equity of 3.26%, indicating operational efficiency.
Is Proto Labs, Inc. overvalued or undervalued?
As of November 28, 2025, Proto Labs, Inc. is fairly valued with a P/E ratio of 44 and an EV to EBITDA ratio of 13.93, outperforming the S&P 500 year-to-date with a 30.01% return, but showing significant long-term volatility with a 5-year return of -63.37%.
Is Proto Labs, Inc. overvalued or undervalued?
As of November 28, 2025, Proto Labs, Inc. is fairly valued with a P/E ratio of 44, having outperformed the S&P 500 over the past year with a 24.56% return, but its 5-year return of -63.37% indicates a challenging long-term outlook.
Is Proto Labs, Inc. overvalued or undervalued?
As of November 21, 2025, Proto Labs, Inc. is considered very expensive and overvalued, with a high P/E ratio of 44 and a PEG ratio of 4.96, significantly outpacing its peers and showing a concerning long-term performance decline despite a strong year-to-date return.
Is Proto Labs, Inc. overvalued or undervalued?
As of November 7, 2025, Proto Labs, Inc. is considered very expensive with a P/E ratio of 44 and overvaluation compared to peers, despite strong year-to-date returns of 25.43%, but its long-term performance has been poor, raising concerns about the sustainability of its high valuation.
Is Proto Labs, Inc. overvalued or undervalued?
As of November 7, 2025, Proto Labs, Inc. is considered overvalued with a valuation grade of "very expensive," reflected in its high P/E ratio of 44 and a significant decline of 62.60% over the past five years, despite a strong year-to-date return of 25.33%.
Is Proto Labs, Inc. technically bullish or bearish?
As of October 31, 2025, Proto Labs, Inc. shows a mildly bullish trend with mixed technical signals, having outperformed the S&P 500 year-to-date and over the past year, but underperformed over the longer 3- and 5-year periods.
Is Proto Labs, Inc. technically bullish or bearish?
As of October 31, 2025, Proto Labs, Inc. has a mildly bullish technical trend, supported by bullish MACD and KST indicators, despite mixed signals from Dow Theory and a neutral RSI.
Proto Labs, Inc. Experiences Valuation Adjustment Amid Strong Yearly Performance Metrics
Proto Labs, Inc. has recently adjusted its valuation, with its current price at $49.76. Over the past year, the company has achieved an impressive return of 81.61%. Key financial metrics include a P/E ratio of 44 and a return on equity of 3.12%, indicating its operational efficiency within the specialty chemicals sector.
Is Proto Labs, Inc. technically bullish or bearish?
As of October 31, 2025, Proto Labs, Inc. shows a mildly bullish trend with positive MACD and KST indicators, but mixed signals from Dow Theory suggest caution despite strong year-to-date and annual performance compared to the S&P 500.
Is Proto Labs, Inc. technically bullish or bearish?
As of October 31, 2025, Proto Labs, Inc. exhibits a mildly bullish technical trend, supported by bullish MACD and KST indicators, despite mixed signals from Dow Theory, while outperforming the S&P 500 year-to-date and over the past year.
Proto Labs Adjusts Valuation Grade Amidst Strong Yearly Performance and Investor Confidence
Proto Labs, Inc. has recently experienced a change in its valuation grade, moving to a fair classification. Key financial metrics include a P/E ratio of 44 and a Price to Book Value of 1.39. The company has shown a significant return over the past year, outperforming the S&P 500.
Is Proto Labs, Inc. overvalued or undervalued?
As of October 24, 2025, Proto Labs, Inc. is fairly valued with a P/E ratio of 44, strong recent performance with a 1-year stock return of 103.65%, but a volatile history reflected in a 5-year return of -60.19% compared to the S&P 500's 95.99%.
Proto Labs, Inc. Experiences Valuation Adjustment Amid Strong Performance Metrics
Proto Labs, Inc. has recently adjusted its valuation, with its stock price at $54.64. Over the past year, the company has achieved a 103.65% return, significantly surpassing the S&P 500. Key financial metrics include a P/E ratio of 44 and a return on equity of 3.12%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
